Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002259
UniProt IDQ8WZA1
Primary gene name(s)POMGNT1
Synonym gene name(s)MGAT1.2
Protein nameProtein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1
Protein functionParticipates in O-mannosyl glycosylation. May be responsible for the synthesis of the GlcNAc(beta1-2Man(alpha1-O-Ser/Thr moiety on alpha-dystroglycan and other O-mannosylated proteins. Is specific for alpha linked terminal mannose and does not have MGAT3, MGAT4, MGAT5, MGAT7 or MGAT8 activity. {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540, ECO:0000269|PubMed:26908613, ECO:0000269|PubMed:27391550}.
Subcellular locationGolgi apparatus membrane {ECO:0000305};
Single-pass type II membrane protein {ECO:0000305}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q8WZA1
Gene Ontology
(Biological Process)
Complete annatation
protein O-linked glycosylation [GO:0006493]
Gene Ontology
(Molecular Function)
Complete annatation
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]
Gene Ontology
(Cellular Component)
Complete annatation
Golgi membrane [GO:0000139];
integral component of membrane [GO:0016021]
Protein-protein interaction120763
Phylogenetic treeQ8WZA1
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.6042883912662570.06630025737260430.125726909803711
AZA vs. DISU-0.2742625892274490.2802151772754370.850816647425599
AZA vs. IL7-0.01485405893194120.9388230302994140.999311006273513
AZA vs. SAHA-0.1448310773626090.5546709682117570.848577476219487
DISU vs. CD3-0.8912005758109490.01490268737156360.0404252491342362
DISU vs. IL70.2499404820329060.3228090018490970.703286120821743
DISU vs. SAHA0.1319108428594410.6522862860411440.892375542314402
DMSO vs. AZA0.03169851732125720.8511550074725371
DMSO vs. CD3-0.5869034061475540.06779742771664130.124118149052279
DMSO vs. DISU0.3033660110093020.2155368117756190.727304020031028
DMSO vs. IL7-0.03877364746364610.8303579170933760.963051812112721
DMSO vs. SAHA-0.180973769516020.4449994727801680.777395045122281
HIV vs. Mock in Activation-0.01450208329662120.981397385123940.999983755607037
HIV vs. Mock in Latency-0.03896790514810760.8144399319559370.999834320637052
IL7 vs. CD3-0.6131436630327310.05804510385487270.124136471396779
SAHA vs. CD3-0.7724053474974850.0297187803360970.0643110309685499
SAHA vs. IL7-0.1321384122592770.5898093536018830.791003394861061
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.100621 0.591929
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
5GGF X-ray 2.4Å A/B/C=92-660.
5GGG X-ray 3.0Å A=92-660.
5GGI X-ray 2.6Å A/B=92-660.
5GGJ X-ray 1.4Å A/B=92-250.
5GGK X-ray 1.3Å A/B=92-250.
5GGL X-ray 1.2Å A/B=92-250.
5GGN X-ray 1.2Å A/B=92-250.
5GGO X-ray 1.5Å A/B=92-250.
5GGP X-ray 1.6Å A/B=92-250.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00515 Mannose type O-glycan biosynthesis - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
Menu